GlassScriptPhysician profile
Joseph Frederick Buell
NPI 1083682009
$186,200.52
in general payments reported to CMS, 2019-2025
34 companies · $3,414 in 2025
The $3,414 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $29K · 2021: $33K · 2022: $22K · 2023: $677 · 2024: $5,313 · 2025: $3,414.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,690 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Travel and Lodging: $2,205 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,690.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Travel and Lodging | $2,205.02 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $73,609.87 | 2019-2021 | |
| Davol INC. | $65,606.43 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Covidien LP | $18,181.94 | 2019-2020 | |
| Biom'Up Sa | $6,896.40 | 2019 | |
| Acell, INC. | $6,538.17 | 2019-2020 | |
| Intuitive Surgical, INC. | $5,699.32 | 2019-2025 | |
| Medtronic, INC. | $3,583.89 | 2021-2025 | Signia, Emprint, Endoflip |
| Tela Bio, INC. | $2,075.95 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $1,040.62 | 2019-2025 | Vistaseal, Echelon; Endopath, Echelon Endopath |
| Kerecis Limited | $482.39 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ethicon INC. | $435.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $395.25 | 2022-2025 | Phasix Mesh |
| Dilon Technologies, INC. | $237.29 | 2023-2025 | Hemoblast Bellows |
| Bard Access Systems, INC. | $188.14 | 2019 | |
| Abbvie INC. | $165.05 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps, Creon |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $164.76 | 2020-2025 | Arista |
| Sirtex Medical INC | $128.42 | 2023-2024 | Sir-Spheres Microspheres |
| Teleflex LLC | $102.78 | 2025 | Quikclot |
| Astrazeneca Pharmaceuticals LP | $86.84 | 2023-2024 | Andexxa, Imfinzi |
| Angiodynamics, INC. | $79.59 | 2025 | Nanoknife |
| Novartis Pharmaceuticals Corporation | $78.38 | 2024-2025 | |
| Aimmune Therapeutics, INC. | $68.61 | 2024-2025 | Zenpep |
| Takeda Pharmaceuticals U.S.A., INC. | $58.63 | 2023-2025 | Gattex |
| Integra Lifesciences Corporation | $50.66 | 2023-2024 | Integra, Codman Hakim, Duraseal Exact Spinal Sealant System |
| Alcresta Therapeutics, INC. | $50.46 | 2024 | Relizorb |
| Innovation Technologies INC | $36.43 | 2020-2024 | Irrisept |
| Acera Surgical, INC. | $33.81 | 2024-2025 | Restrata Wound Matrix |
| Intera Oncology, INC | $27.55 | 2024 | Intera |
| Eisai INC. | $23.97 | 2019 | |
| Tersera Therapeutics LLC | $23.45 | 2025 | Xermelo |
| Baxter Healthcare | $19.63 | 2023 | Perclot |
| Recordati_rare_diseases_inc. | $16.66 | 2024 | Sylvant |
| Vivus LLC | $14.18 | 2024 | Qsymia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Buell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.